embecta Belgium SRL
6.3 FTEThe score of embecta Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +25 % Total assets +1 % Headcount (avg FTE) +29 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
embecta Belgium's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 11 May 2026
- Year ended 30 Sep 2024filed on 24 Feb 2026
- Year ended 30 Sep 2023filed on 02 Jun 2025
- Year ended 30 Sep 2022filed on 29 Mar 2024
embecta Belgium's financial analysis
- Solvency63.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of embecta Belgium
embecta Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0771.280.454
- VAT number
- BE0771280454
- Peppol
- Registered · 9925:be0771280454 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Jul 2021
- Registered office
- 2600 Antwerp
- Size
- Micro · 6.3 FTE
- Latest accounts
- 2025 · filed on 11 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
embecta Belgium (SRL) has been based in Antwerp since 2021, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 116,110 € and equity of €2.03m; its revenue is not published. With 6.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 63.7%, above the median of its sector (46.0%).
Companies similar to embecta Belgium
Companies in the same business, of comparable size and area, outside its group.
- Schwabe Pharma Belgium Wholesale of pharmaceutical and medical goods Kontich · balance sheet €3.13m
- F Care Systems Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €3.15m
- Alexion Pharma Belgium Manufacture of pharmaceutical preparations Brussels · balance sheet €8.68m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
- Sasmar Pharmaceuticals Wholesale of pharmaceutical and medical goods Overijse · balance sheet €3.07m
- Novolab Wholesale of pharmaceutical and medical goods Geraardsbergen · balance sheet €3.37m
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Sterop Overseas Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €4.07m
Frequently asked questions about embecta Belgium
What is the revenue of embecta Belgium?
embecta Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of embecta Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0771280454 for embecta Belgium, if the company is VAT-registered. Its company number (CBE) is 0771.280.454.
Where is the registered office of embecta Belgium?
According to the CBE register, the registered office of embecta Belgium is in 2600 Antwerp.
What is the equity of embecta Belgium?
At the close of the 2025 financial year, the equity of embecta Belgium amounts to 2,026,333 €, a solvency of 63.7% of total assets.
How many people work at embecta Belgium?
6.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages embecta Belgium?
The register lists 3 active mandates at embecta Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of embecta Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →